✦ LIBER ✦

The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)

✍ Scribed by Margaret F. Bevans; Sandra A. Mitchell; Susan Marden

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 362 KB
Volume: 16
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-008-0420-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic hematopoietic stem cell trans

Allogeneic hematopoietic stem cell transplantation in ovarian cancer—the EBMT experience

✍ Jacques-Olivier Bay; Aurélie Cabrespine-Faugeras; Reza Tabrizi; Didier Blaise; P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB

## Abstract Although preliminary results suggest that allogeneic hematopoietic stem cell transplantation (allo HCT) for ovarian cancer (OC) is a feasible procedure, the low patient number in previous studies had limited ability to evaluate the true benefit of allo HCT in OC. This retrospective mult

Regression of the tumor after withdrawal

Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation

✍ Shinichi Kako; Koji Izutsu; Kumi Oshima; Hiroyuki Sato; Yoshinobu Kanda; Toru Mo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Twenty Years’ Experience in Allogeneic H

Twenty Years’ Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group

✍ Hiroatsu Iida; Hiroshi Sao; Kenjiro Kitaori; Seiichi Gotoh; Makoto Yazaki; Seiji 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 98 KB

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets